2m 2m 2m 2m 2m 2m 2m
TEVOGEN BIO (TVGN)
NASDAQ
$5.01+$0.005 (+0.10%)
Price as of Jul 14, 2026 7:00 AM EDT- $21.1MMarket Cap
- -92.06%1-Year Change
- BiotechnologyIndustry
TEVOGEN BIO (TVGN)
$5.01+$0.005 (+0.10%)
TVGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.00 | ||
Change | -$0.06 (-1.19%) | ||
Open | $5.11 | ||
High | $5.19 | ||
Low | $5.00 | ||
Previous Close | $5.06 | ||
Volume | 14,823 | ||
30-Day Average Volume | 22,080 | ||
1-Week Change | -14.68% | ||
1-Month Change | -52.24% | ||
1-Year Change | -92.06% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.2M | ||
Total Assets | $4.9M | ||
Market Cap | $21.1M | ||
Enterprise Value | $22.1M | ||
Period: QTR TTM FY | |||
Revenue | -$71,166.00 | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$2.7M | ||
EBIT | -$5.6M | ||
EBITDA | -$5.5M | ||
Net Working Capital | -$5.1M | ||
EPS | -$1.61 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | -310 | ||
P/B | N/A | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 03/06/2026 | ||
Earnings & Revenue